Evidence map›Paper›PMID 41662056›Full record

ArticlePLOS mental health2025

Scope of anti-stigma programs against Alzheimer's disease: A scoping review.

Sandra Paola Mondragón Bohórquez, Carolina Gutiérrez-López

Abstract read
In one paragraph

Article in PLOS mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sandra Paola Mondragón BohórquezFacultad de Medicina/Programa Doctorado en Salud Pública/Universidad El Bosque, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-3026-9946
Carolina Gutiérrez-LópezFacultad de Medicina/Coordinador de la Línea de Investigación Educación en Salud del Doctorado en Salud Pública/Universidad El Bosque, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-3984-1072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study identifies and reports evidence related to key guidelines for intervention programs aimed at reducing social stigma associated with Alzheimer's Disease. This scoping review followed the methodology of the Joanna Briggs Institute. The databases searched included: SCOPUS, PubMED, Science Direct, Taylor and Francis, Google Scholar, JBI, Prospero, and Cochrane Library. The STROBE statement was used to organize and draft the protocol. Of the 2275 initial studies, 22 articles were identified for the analysis of emerging categories: social stigma assessment, measurement, and intervention strategies. Of the 2275 initial studies, 22 articles were analysed for the purpose of identifying emerging categories: social stigma assessment, measurement and intervention strategies. Programmes against stigma addressed the following aspects: clinical and epidemiological knowledge and information; emotions, care and impact on patients' lives; general information on the disease; dementia-friendly communities; a multimedia campaign on stigmatising beliefs; digital platforms; support in the arts; knowledge and clinical aspects; bilingual presentations adapted to the culture; and awareness and knowledge about Alzheimer's disease. The most common strategies were: patient and intergenerational contact, life stories [vignettes], theatre, music, art, adapting content for culture, curriculum work, discussion groups and health education. The evidence suggests that the content of educational programs and interventions should focus on promoting understanding of the disease, working with groups or peers with the same condition, and generating intergenerational contact, affectionate bonds, and emotional expression to reduce social stigma.

Identifiers

PMID41662056
PMCPMC12798474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.